so they have not been successful with placing the analyzers in urban hospitals because such hospitals already have tests they are very satisfied with and don't really need a slightly faster or cheaper test. Thus, GB's market is very limited it seems.
Does anyone on this board work for a hospital that has a Great Basin Analyzer? If so, please enlighten us with regard to its usage and impressions by hospital laboratory staff who conduct the diagnostic tests. I wonder if the Great Basin tests are views as a significant improvement (accuracy or speed) over the alternative testing methodology or if the GB tests are not much better or have some problems/issues.
maybe the haste to do another RS is due to knowing the stock was about to be delisted or down-listed, and waiting another day or week was NOT an option. They knew they needed to get the approval and only squeaked by with a 53% vote, and I suspect would not have had the majority before the FDA approval.